Back
Relay Therapeutics Stock Price Chart
Sponsored
RLAY
Sponsored
"EarnPhone": The Investment Hidden in Plain Sight
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
31
RLAY
Relay Therapeutics
Last Price:
7.86
Seasonality Move:
-5.33%
7 Day Trial
ALL ACCESS PASS
$
7
Free 23-page book shares my #1 indicator to use
Here's the 23-page free book.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RLAY is experiencing slight selling pressure.
Relay Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 8.1 | Sell |
20-day SMA: | 7.33 | Buy |
50-day SMA: | 7.6 | Sell |
200-day SMA: | 8.23 | Sell |
8-day EMA: | 7.68 | Sell |
20-day EMA: | 7.48 | Buy |
50-day EMA: | 7.39 | Buy |
200-day EMA: | 8.22 | Sell |
Relay Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.16 | Buy |
Relative Strength Index (14 RSI): | 51.35 | Buy |
Chaikin Money Flow: | -606265 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (6.45 - 8.01) | Buy |
Bollinger Bands (100): | (6.39 - 8.03) | Buy |
Relay Therapeutics Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Relay Therapeutics Stock
Is Relay Therapeutics Stock a Buy?
- Relay Therapeutics share price is 7.58 while RLAY 8-day simple moving average is 8.10, which is a Sell signal.
- The stock price of RLAY is 7.58 while Relay Therapeutics 20-day SMA is 7.33, which makes it a Buy.
- Relay Therapeutics 50-day simple moving average is 7.60 while RLAY share price is 7.58, making it a Sell technically.
- RLAY stock price is 7.58 and Relay Therapeutics 200-day simple moving average is 8.23, creating a Sell signal.
RLAY Technical Analysis vs Fundamental Analysis
Sell
31
Relay Therapeutics (RLAY)
is a Sell
Is Relay Therapeutics a Buy or a Sell?
-
Relay Therapeutics stock is rated a Sell
The current Relay Therapeutics [RLAY] share price is $7.58. The Score for RLAY is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
Relay Therapeutics Stock Info
Market Cap:
1.01B
Price in USD:
7.58
Share Volume:
1.48M
Relay Therapeutics 52-Week Range
52-Week High:
12.14
52-Week Low:
5.70
Sell
31
Relay Therapeutics (RLAY)
is a Sell
Relay Therapeutics Share Price Forecast
-
What is the Relay Therapeutics stock price today?
The Relay Therapeutics stock price is 7.58 USD today. -
Will RLAY stock go up or go down?
Relay Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Relay Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Relay Therapeutics is overvalued.
Is Relay Therapeutics Stock a Buy?
- Relay Therapeutics share price is 7.58 while RLAY 8-day exponential moving average is 7.68, which is a Sell signal.
- The stock price of RLAY is 7.58 while Relay Therapeutics 20-day EMA is 7.48, which makes it a Buy.
- Relay Therapeutics 50-day exponential moving average is 7.39 while RLAY share price is 7.58, making it a Buy technically.
- RLAY stock price is 7.58 and Relay Therapeutics 200-day simple moving average is 8.22, creating a Sell signal.
Fundamental Analysis of Relay Therapeutics
Is Relay Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.01 per share, an increase this year of $0.03 per share, and a decrease next year of $0.24 per share.
Technical Analysis of Relay Therapeutics
Should I short Relay Therapeutics stock?
- RLAY Moving Average Covergence Divergence (MACD) indicator is 0.16, suggesting Relay Therapeutics is a Buy
- Relay Therapeutics Relative Strength Index (RSI) is 51.35, which suggest Relay Therapeutics is overbought
- The Bollinger Bands (25) for Relay Therapeutics is (6.45 - 8.01), which suggest Relay Therapeutics is a Buy
- The Bollinger Bands (100) for Relay Therapeutics is (6.39 - 8.03), which suggest Relay Therapeutics is a Buy
* Relay Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.